Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Dolomite double sales in 2009

Abstract:
Innovative products and custom design prove key to success

Dolomite double sales in 2009

Royston, UK | Posted on January 20th, 2010

Dolomite, a world leader in microfluidic design and manufacture, reported exceptional growth in 2009, doubling its year on year turnover, with a significant improvement in profitability. With numerous new product launches throughout the year, Dolomite has been able to provide both standard solutions and custom designs for microfluidic devices, sub-systems and instrumentation.

Furthermore, 2010 shows great promise with an expanded team, including two recently appointed European Business Development Managers, and an increasing demand from existing and new sectors. Andrew Lovatt, newly-appointed CEO, commented, "Microfluidics is becoming increasingly important in many sectors and Dolomite's offerings cover everything from standard devices to complete bespoke instrumentation development. As a result, we are uniquely positioned to assist our clients in maximising their success in this exciting new market."

Having launched six new products, including the Mitos XS-pump and the Mitos P-Pump (pressure) for extra smooth flow, as well as eight new standard micro-fluidic devices such as the Y-junction Chip and the Mitos Droplet Junction Chip, Dolomite is rapidly increasing its product range to meet user requirements. With an extended range of production processes, Dolomite has mastered the optimisation of quartz microfluidic chip fabrication. Consequently, instrument manufacturers not only benefit from this expertise and experience, but also from the properties of synthetic quartz within bioscience and medical systems.

For further information on the complete range of microfluidic products available from Dolomite, including chips, connectors/interconnects, pumps, valves and flow sensors, please visit www.dolomite-microfluidics.com.

####

About Dolomite
Dolomite is a global leader in the design and manufacture of microfluidics devices. With offices in the UK, US and Japan and distributors throughout the rest of the world, its clients range from universities developing leading-edge analytical equipment, to manufacturers of chemical, life sciences and clinical diagnostics systems.

Excellent microfabrication facilities that include cleanrooms, precision glass processing facilities and applications laboratories were established with £2m in funding from the UK Department of Trade and Industry's Micro and Nano Technology (MNT) Manufacturing Initiative. Dolomite’s expertise includes top quality engineering and scientific staff with strong backgrounds across the broad range of disciplines required for success in bringing microfluidics applications to the market, including chemistry, biotechnology, control system development, electronics, physics and instrument design and supply.

For more information, please click here

Contacts:
Product enquiries
Dolomite
Andrew Lovatt
+44 1763 242491


Media enquiries
Alto Marketing Limited
Carolyn Butchers
+44 (0)1489 557672

Copyright © Dolomite

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Microfluidics/Nanofluidics

Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023

Computational system streamlines the design of fluidic devices: This computational tool can generate an optimal design for a complex fluidic device such as a combustion engine or a hydraulic pump December 9th, 2022

Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022

Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Tools

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

Turning up the signal November 8th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024

Appointments/Promotions/New hires/Resignations/Deaths

The National Space Society Mourns the Passing of Robert Krone, Founder of the Kepler Space Institute: Krone's Visionary and Humanistic Approach to the Study of Space Communities and Settlement Was Unique September 22nd, 2021

Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021

JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021

The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project